From the Sector

Reset
3 results
06.05.2020

CHT teams up with HeiQ in fight against COVID-19

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The HeiQ Viroblock NPJ03 that has been developed by HeiQ is a new technology that is also effective against Coronaviruses (229E) thanks to its antibacterial and antiviral properties. Comprehensive studies have demonstrated the kit‘s effectiveness. A combination of silver salts with a vesicle technology deactivates bacteria and viruses on textile surfaces within a few minutes and renders the bacteria and viruses harmless. Textiles equipped in this way reduce the rate of infection by 99.99%, which stops the transmission and the spread of bacteria and viruses through textiles.

Viroblock can be used on all types of fibers – not only for protective kit and masks, but also for work clothing, bed linen, towels and home textiles. The kit is wash-resistant and still highly effective after 30 standard wash processes.

More information:
HeiQ CHT Group corona virus
Source:

CHT Gruppe

Devan (c) Devan
25.03.2020

Devan offers antiviral solutions for textiles' professional workers

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Over the past few weeks, Devan has received a lot of questions regarding an antiviral solution for textiles against Sars-COV-2, the virus that causes COVID-19. “Not a big surprise since we put BI-OME AV forward 3 years ago. Testing has been done in cooperation with Institut Pasteur de Lille”, says Devan CEO Sven Ghyselinck. Devan studied enveloped viruses (e.g. H1N1, Corona-types, etc.) as well as naked viruses (e.g. Rotavirus). For both virus families, BI-OME AV showed strong to excellent activity in wet state.

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Over the past few weeks, Devan has received a lot of questions regarding an antiviral solution for textiles against Sars-COV-2, the virus that causes COVID-19. “Not a big surprise since we put BI-OME AV forward 3 years ago. Testing has been done in cooperation with Institut Pasteur de Lille”, says Devan CEO Sven Ghyselinck. Devan studied enveloped viruses (e.g. H1N1, Corona-types, etc.) as well as naked viruses (e.g. Rotavirus). For both virus families, BI-OME AV showed strong to excellent activity in wet state.

In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers, … A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odor build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.

Devan has solutions which withstand washing while keeping its performance. BI-OME as a liquid product is EU BPR, Turkish BPR and US EPA registered. Depending on the rash region, commercialising treated articles be subject to additional local registration procedures.

More information:
Devan Coronavirus
Source:

Devan

25.03.2020

DEVAN: Antiviral solutions for textiles

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.
 

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.
 

More information:
Devan face masks antiviral
Source:

Marketing Solutions NV